Since 2010, scientists have published over 23,000 peer-reviewed papers on cannabis, with the annual number of papers increasing every year.
For over five decades, federal regulators have only authorized a single licensee – the University of Mississippi – to cultivate cannabis plants for use in FDA-approved clinical studies.
“These common-sense regulatory changes are necessary and long overdue. The reality that most high-schoolers have easier access to cannabis than do our nation’s top scientists is the height of absurdity and an indictment of the current system.”
“We found that workers reporting using cannabis more than once in the past year were no more likely to report having experienced a work-related injury over the same time period in a large cohort of the Canadian working population.”
“Using a large dataset of medical cannabis users self-medicating for symptoms of OCD, we found that for the vast majority of cannabis use sessions individuals reported reductions in intrusions, compulsions, and anxiety.”
“Current or ever use of cannabis for menopause symptom management was reported by 27 percent of all participants, while an additional 10 percent expressed interest in future use.”
“In this sample of individuals with neuropathic pain, no significant differences were found in cognitive performance between non-MC [medical cannabis] licensed and licensed patients.”
Some 30 percent of migraine patients have used cannabis to mitigate migraine pain. Among these users, 82 percent reported it to be effective at providing migraine relief.